ClinicalTrials.gov
public full text
Public Domain
Beijing Protocol in Patients Receiving More Than 5/10 HLA-mismatched Allo-HSCT
The aim of the study is to evaluate the efficacy and safety of Beijing protocol in malignant haematologic disease patients receiving more than 5/10 HLA-mismatched allo-HSCT.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients#897398
- To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307#913717
- Assessing Hp Diagnosis and Treatment Quality of direct-to Consumer Telemedicine in Mainland China#827737
- Guangdong Uptake of Surgery Trial#894017
- FALCOn (Facteur AnthropoLogique Cancer Orl)#883295
Record · ID 915461
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive